January 19, 2023

New Frontiers for Neurology Laboratory Medicine

Ultrasensitive immunoassays have launched an explosion of research on blood biomarkers for a variety of...

December 14, 2022

Exploring the Role of IFNa in Autoimmunity and Infection

Abstract: Type I interferons (IFNs) are essential mediators of antiviral responses. These cytokines...

October 18 & 20, 2022

Simoa® Mini-Symposium Roadshows

In these on-demand symposium recordings, you'll hear about the single molecule detection system of Simoa for...

August 25, 2022

Ultra-Sensitive IL-11 Target Engagement Assay Development

Interleukin-11 (IL-11) is an interesting and unique pleiotropic cytokine, originally characterized as a...

June 21, 2022

Detecting Alzheimer’s Disease Pathology in Blood

Exploring applications for therapeutic trials and clinical use The development of blood biomarkers...

May 11, 2022

Employing Serum NfL Measurements for Management of Multiple Sclerosis

Multiple sclerosis (MS) affects close to 3 million people worldwide, and incidence rates have risen over the...

April 11, 2022

Post-AD/PD 2022 Webinar and Q&A: Simoa® highlights

Our Field Applications Scientist Danilo La Terra recently presented some of the Simoa® highlights from...

September 9, 2021

Cytokine Profiles and Personalized Therapeutics in COVID-19 Patients

Recent observations by Prof. Gorochov’s team at the CIMI Research Centre suggest that there are at least...

April 23, 2021

at 10:00 am EDT

Recent Advancements in Neurodegenerative Biomarkers: Progress Towards a Diagnostic Blood Test for Alzheimer’s Disease

With much enthusiasm following the research coming out of AD/PD™2021, we are pleased to bring together...